vs
Princeton Bancorp, Inc.（BPRN）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Princeton Bancorp, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$20.7M vs $19.6M），Princeton Bancorp, Inc.净利率更高（29.3% vs -177.4%，领先206.7%），Princeton Bancorp, Inc.同比增速更快（3.6% vs -11.5%），Princeton Bancorp, Inc.自由现金流更多（$20.6M vs $-23.1M），过去两年Princeton Bancorp, Inc.的营收复合增速更高（9.1% vs -12.2%）
普林斯顿银行控股公司是一家总部位于美国的银行控股企业，通过旗下社区银行子公司开展业务，提供零售与商业银行全品类服务，包括存款账户、中小企业贷款、个人消费贷款、抵押贷款及财富管理服务，主要服务新泽西州及美国中大西洋地区客户。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BPRN vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.7M | $19.6M |
| 净利润 | $6.1M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 38.2% | -168.5% |
| 净利率 | 29.3% | -177.4% |
| 营收同比 | 3.6% | -11.5% |
| 净利润同比 | 16.3% | -28.8% |
| 每股收益（稀释后） | $0.89 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $20.7M | — | ||
| Q3 25 | $21.5M | $19.6M | ||
| Q2 25 | $21.1M | $21.8M | ||
| Q1 25 | $20.9M | $40.8M | ||
| Q4 24 | $20.0M | — | ||
| Q3 24 | $19.2M | $22.1M | ||
| Q2 24 | $18.1M | $22.5M | ||
| Q1 24 | $17.4M | $45.5M |
| Q4 25 | $6.1M | — | ||
| Q3 25 | $6.5M | $-34.7M | ||
| Q2 25 | $688.0K | $-33.5M | ||
| Q1 25 | $5.4M | $-26.0M | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $-4.5M | $-26.9M | ||
| Q2 24 | $5.1M | $-45.7M | ||
| Q1 24 | $4.3M | $-32.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | 38.2% | — | ||
| Q3 25 | 38.5% | -168.5% | ||
| Q2 25 | 2.8% | -118.1% | ||
| Q1 25 | 32.9% | -80.8% | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | -29.1% | -120.9% | ||
| Q2 24 | 34.1% | -134.5% | ||
| Q1 24 | 31.0% | -132.2% |
| Q4 25 | 29.3% | — | ||
| Q3 25 | 30.0% | -177.4% | ||
| Q2 25 | 3.3% | -153.7% | ||
| Q1 25 | 25.7% | -63.8% | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | -23.3% | -122.0% | ||
| Q2 24 | 28.4% | -203.3% | ||
| Q1 24 | 24.9% | -70.6% |
| Q4 25 | $0.89 | — | ||
| Q3 25 | $0.95 | $-0.09 | ||
| Q2 25 | $0.10 | $-0.09 | ||
| Q1 25 | $0.77 | $-0.07 | ||
| Q4 24 | $0.75 | — | ||
| Q3 24 | $-0.68 | $-0.07 | ||
| Q2 24 | $0.80 | $-0.12 | ||
| Q1 24 | $0.68 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $270.7M | $399.7M |
| 总资产 | $2.3B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $10.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
| Q4 25 | $270.7M | — | ||
| Q3 25 | $266.6M | $399.7M | ||
| Q2 25 | $261.9M | $424.5M | ||
| Q1 25 | $267.0M | $454.6M | ||
| Q4 24 | $262.0M | — | ||
| Q3 24 | $261.5M | $489.3M | ||
| Q2 24 | $244.8M | $510.3M | ||
| Q1 24 | $241.8M | $577.3M |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | $539.6M | ||
| Q2 25 | $2.2B | $557.0M | ||
| Q1 25 | $2.3B | $579.6M | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.4B | $681.5M | ||
| Q2 24 | $2.0B | $708.7M | ||
| Q1 24 | $2.0B | $777.7M |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.5M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $20.6M | $-23.1M |
| 自由现金流率自由现金流/营收 | 99.3% | -118.1% |
| 资本支出强度资本支出/营收 | 4.3% | 4.5% |
| 现金转化率经营现金流/净利润 | 3.54× | — |
| 过去12个月自由现金流最近4个季度 | $29.2M | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $21.5M | — | ||
| Q3 25 | $4.9M | $-22.2M | ||
| Q2 25 | $3.1M | $-20.7M | ||
| Q1 25 | $1.3M | $-30.3M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $1.2M | $-27.9M | ||
| Q2 24 | $4.3M | $-39.0M | ||
| Q1 24 | $4.8M | $-62.5M |
| Q4 25 | $20.6M | — | ||
| Q3 25 | $4.7M | $-23.1M | ||
| Q2 25 | $2.9M | $-22.6M | ||
| Q1 25 | $1.1M | $-35.3M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $766.0K | $-30.1M | ||
| Q2 24 | $3.9M | $-41.0M | ||
| Q1 24 | $4.8M | $-63.3M |
| Q4 25 | 99.3% | — | ||
| Q3 25 | 21.6% | -118.1% | ||
| Q2 25 | 13.7% | -103.6% | ||
| Q1 25 | 5.0% | -86.6% | ||
| Q4 24 | 65.9% | — | ||
| Q3 24 | 4.0% | -136.4% | ||
| Q2 24 | 21.8% | -182.2% | ||
| Q1 24 | 27.3% | -138.9% |
| Q4 25 | 4.3% | — | ||
| Q3 25 | 1.1% | 4.5% | ||
| Q2 25 | 1.2% | 8.7% | ||
| Q1 25 | 1.0% | 12.4% | ||
| Q4 24 | 7.6% | — | ||
| Q3 24 | 2.2% | 10.2% | ||
| Q2 24 | 2.1% | 8.6% | ||
| Q1 24 | 0.4% | 1.7% |
| Q4 25 | 3.54× | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 4.57× | — | ||
| Q1 25 | 0.23× | — | ||
| Q4 24 | 2.82× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BPRN
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
